Articles in Scholarly Journals [Incomplete List]

1. CYP2C9 Protein Interactions with Cytochrome b5: Effects on the Coupling of Catalysis
   Drug Metabolism and Disposition, vol. 35, no. 7, pp. 1174–1181, 2007
2. Chemical Research in Toxicology, vol. 19, no. 12, pp. 1650–1659, 2006
3. Mechanism of Inactivation of Human Cytochrome P450 2B6 by Phencyclidine
   Drug Metabolism and Disposition, vol. 34, no. 9, pp. 1523–1529, 2006
4. The in Vitro Drug Interaction Potential of Dietary Supplements Containing Multiple Herbal Components
   Drug Metabolism and Disposition, vol. 35, no. 2, pp. 185–188, 2006
5. Predicting in vivo drug interactions from in vitro drug discovery data
   Nature Reviews Drug Discovery, vol. 4, no. 10, Article ID nrd1851, 8 pages, 2005
6. Catalytic turnover of pyrene by CYP3A4: Evidence that cytochrome directly induces positive cooperativity
   Archives of Biochemistry and Biophysics, 2005
7. Chemical Research in Toxicology, vol. 17, no. 2, pp. 174–184, 2004
8. IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMES
   Drug Metabolism and Disposition, vol. 31, no. 7, pp. 878–887, 2003
9. Activation of cytochrome P450 2C9-mediated metabolism: mechanistic evidence in support of kinetic observations
   Archives of Biochemistry and Biophysics, vol. 410, no. 1, pp. 16–24, 2003
10. Effect of carbonate anion on cytochrome P450 2D6-mediated metabolism in vitro: the potential role of multiple oxygenating species
    Archives of Biochemistry and Biophysics, vol. 417, no. 2, pp. 165–175, 2003
11. Journal of Medicinal Chemistry, vol. 46, no. 2, pp. 284–302, 2003
12. Chemical Research in Toxicology, vol. 16, no. 4, pp. 450–459, 2003
13. Characterization of bropirimine O -glucuronidation in human liver microsomes
    Xenobiotica, vol. 33, no. 10, pp. 999–1011, 2003
14. Pyrene·Pyrene Complexes at the Active Site of Cytochrome P450 3A4: Evidence for a Multiple Substrate Binding Site
    Journal of the American Chemical Society, vol. 124, no. 40, pp. 11866–11867, 2002
15. Factors confounding the successful extrapolation of in vitro CYP3A inhibition information to the in vivo condition
    European Journal of Pharmaceutical Sciences, vol. 15, no. 3, pp. 239–242, 2002
16. Multiple Cytochrome P450 Enzymes Responsible for the Oxidative Metabolism of the Substituted (S)-3-Phenylpiperidine, (S,S)-3-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine Hydrochloride, in Human Liver Microsomes
    Drug Metabolism and Disposition, vol. 30, no. 12, pp. 1372–1377, 2002
17. Problems associated with in vitro assessment of drug inhibition of CYP3A4 and other P-450 enzymes and its impact on drug discovery
    Journal of Pharmacological and Toxicological Methods, vol. 45, no. 1, pp. 79–84, 2001
18. Covalent Alteration of the CYP3A4 Active Site: Evidence for Multiple Substrate Binding Domains
    Archives of Biochemistry and Biophysics, vol. 391, no. 1, pp. 49–55, 2001
19. Identification of cytochrome P4503A as the major subfamily responsible for the metabolism of roquinimex in man
    Xenobiotica, vol. 30, no. 9, pp. 905–914, 2000
20. Chemical Research in Toxicology, vol. 13, no. 4, pp. 262–270, 2000
21. In vitro metabolic transformations of 2,4- dipyrrolidinylp yrimidine : a chemical probe for P450-mediated oxidation of tirilazad mesylate
    Xenobiotica, vol. 27, no. 11, pp. 1131–1145, 1997